MAFFEI, Rossana
 Distribuzione geografica
Continente #
NA - Nord America 5.024
EU - Europa 2.324
AS - Asia 660
OC - Oceania 12
SA - Sud America 12
AF - Africa 1
Totale 8.033
Nazione #
US - Stati Uniti d'America 5.005
GB - Regno Unito 875
IT - Italia 475
SE - Svezia 298
CN - Cina 250
DE - Germania 236
SG - Singapore 139
HK - Hong Kong 135
UA - Ucraina 114
FI - Finlandia 92
TR - Turchia 76
BG - Bulgaria 50
FR - Francia 48
RU - Federazione Russa 27
BE - Belgio 25
IE - Irlanda 20
ID - Indonesia 18
CZ - Repubblica Ceca 17
VN - Vietnam 16
CA - Canada 14
AU - Australia 12
ES - Italia 12
IN - India 9
NL - Olanda 8
RO - Romania 7
JP - Giappone 6
BZ - Belize 5
LT - Lituania 5
MY - Malesia 5
AR - Argentina 4
BR - Brasile 4
CL - Cile 4
DK - Danimarca 4
AE - Emirati Arabi Uniti 2
GR - Grecia 2
HR - Croazia 2
IR - Iran 2
AM - Armenia 1
AT - Austria 1
CH - Svizzera 1
DZ - Algeria 1
MK - Macedonia 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
Totale 8.033
Città #
Fairfield 784
Southend 733
Woodbridge 469
Ashburn 420
Chandler 413
Houston 412
Seattle 308
Cambridge 272
Ann Arbor 259
Nyköping 243
Wilmington 241
Jacksonville 213
Dearborn 194
Hong Kong 134
Modena 134
Singapore 81
New York 72
Beijing 64
San Diego 61
Fremont 57
Helsinki 55
Princeton 55
Sofia 50
Eugene 46
Izmir 45
Bremen 35
Milan 35
Brussels 25
Rome 24
Redwood City 23
London 22
Dublin 20
Boardman 17
Bologna 17
Des Moines 17
Jakarta 17
Dong Ket 14
Falls Church 14
Munich 13
Brno 12
Frankfurt am Main 11
San Jose 11
Hefei 10
Perugia 10
Phoenix 10
Kilburn 9
Shanghai 9
Chicago 8
Norwalk 8
Bari 7
Dallas 7
Guangzhou 7
Kunming 7
Atlanta 6
Castelnuovo Rangone 6
Jinan 6
Madrid 6
Ottawa 6
Belize City 5
Dongguan 5
Reggio Emilia 5
Saint Petersburg 5
San Francisco 5
San Giuliano Milanese 5
Amsterdam 4
Ankara 4
Boretto 4
Chiswick 4
Genoa 4
Grafing 4
Hounslow 4
Las Vegas 4
Leawood 4
Los Angeles 4
Nanjing 4
Naples 4
Parma 4
São Paulo 4
Toronto 4
Treviso 4
Verona 4
Wuhan 4
Barcelona 3
Buenos Aires 3
Castelnovo ne' Monti 3
Civitanova Marche 3
Clearwater 3
Jinhua 3
Moscow 3
Perth 3
Saint Louis 3
Shenyang 3
Southwark 3
Sydney 3
Wandsworth 3
Albuquerque 2
Ancona 2
Baotou 2
Brighton 2
Brisbane 2
Totale 6.415
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 407
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 282
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 280
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 243
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 238
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 225
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 212
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 208
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 203
Mucorales-specific T cells in patients with hematologic malignancies 201
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 189
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 188
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 187
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 187
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 187
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 186
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 174
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 172
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 171
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 170
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 170
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 170
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 168
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 167
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 166
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 166
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis. 161
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 153
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 151
Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS 147
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study 147
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 146
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. 145
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 143
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 142
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 133
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 132
IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia. 127
HOXA homeogene cluster interruption and dysregulation of HOAX9 in the blast crisis of Philadelphia chromosome-positive chronic myeloid leukemia. 123
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 118
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. 117
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study 89
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance. 88
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 88
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status 85
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line. 83
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 82
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 81
Performance trade-offs of different rake receivers 56
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 48
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study 24
NOX-A12: Mobilizing CLL away from home 7
Totale 8.133
Categoria #
all - tutte 35.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.715


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.480 0 0 0 85 170 246 351 196 156 85 108 83
2020/20211.640 121 88 127 218 277 134 107 151 75 152 84 106
2021/20221.057 64 134 93 46 29 82 53 53 97 84 215 107
2022/20231.247 128 156 103 114 168 164 15 145 134 12 53 55
2023/2024800 28 36 51 85 149 68 86 110 15 24 63 85
2024/2025213 82 49 29 53 0 0 0 0 0 0 0 0
Totale 8.133